
LINK . SPRINGER . COM {
}
Title:
The effect of anti-VEGF therapy on immature myeloid cell and dendritic cells in cancer patients | Cancer Immunology, Immunotherapy
Description:
Impairment of dendritic cells (DC), the most effective activators of anticancer immune responses, is one mechanism for defective antitumor immunity, but the causes of DC impairment are incompletely understood. We evaluated the association of impaired DC differentiation with angiogenesis-associated molecules D-dimer, vascular endothelial growth factor (VEGF), urokinase plasminogen activator (uPA), and plasminogen activator inhibitor (PAI-1) in peripheral blood from 41 patients with lung, breast, and colorectal carcinoma. Subsequently, we studied the effect of administration of the anti-VEGF antibody (bevacizumab) on DC maturation and function in vivo. Compared with healthy volunteers, cancer patients had a bias toward the immunoregulatory DC2, had deficits in DC maturation after overnight in vitro culture, and had a significant increase in immature myeloid cell progenitors of DC (0.50 ± 0.31% vs. 0.32 ± 0.16% of peripheral blood mononuclear cells, respectively, P = 0.011). A positive correlation was found between the percentage of DC2 and PAI-1 (R = 0.50) and between immature myeloid cells and VEGF (R = 0.52). Bevacizumab administration to cancer patients was associated with a decrease in the accumulation of immature progenitor cells (0.39 ± 0.30% vs. 0.27 ± 0.24%, P = 0.012) and induced a modest increase in the DC population in peripheral blood (0.47 ± 0.23% vs. 0.53 ± 0.30%). Moreover, anti-VEGF antibody treatment enhanced allo-stimulatory capacity of DC and T cell proliferation against recall antigens. These data suggest that DC differentiation is negatively associated with VEGF levels and may be one explanation for impaired anticancer immunity, especially in patients with advanced malignancies.
Website Age:
28 years and 1 months (reg. 1997-05-29).
Matching Content Categories {📚}
- Science
- Health & Fitness
- Education
Content Management System {📝}
What CMS is link.springer.com built with?
Custom-built
No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.
Traffic Estimate {📈}
What is the average monthly size of link.springer.com audience?
🌠 Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 7,642,828 visitors per month in the current month.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Link.springer.com Make Money? {💸}
We're unsure how the site profits.
While profit motivates many websites, others exist to inspire, entertain, or provide valuable resources. Websites have a variety of goals. And this might be one of them. Link.springer.com has a revenue plan, but it's either invisible or we haven't found it.
Keywords {🔍}
cancer, google, scholar, pubmed, cas, article, cells, dendritic, cell, endothelial, patients, growth, factor, vascular, immature, blood, carbone, immunol, myeloid, gabrilovich, res, human, vegf, plasminogen, maturation, differentiation, access, nadaf, privacy, cookies, function, content, lyerly, morse, immune, immunity, activator, peripheral, breast, vivo, data, publish, research, search, immunotherapy, antivegf, timothy, defective, antitumor, pai,
Topics {✒️}
vegf-mediated tumour angiogenesis month download article/chapter circulating d-dimer levels anti-vegf antibody cd40 ligand-induced maturation urokinase-type plasminogen activators related subjects immature myeloid cell dendritic cell induction immature dendritic cells dendritic cell differentiation full article pdf article cancer immunology immature myeloid cells molecules d-dimer nuclear factor-kappa immature progenitor cells circulating human cd34 immunotherapy article privacy choices/manage cookies research triangle park human tumors inhibits tumor-bearing hosts anti-vegf therapy myeloid suppressor cells impaired anticancer immunity hematopoietic progenitor cells defective antitumor immunity anticancer immune responses urokinase plasminogen activator tumour cells plasminogen activator inhibitor functional endothelial precursors antitumor immune responses plasminogen activator system plasminogen activator inhibitors vivo tumor vascularization della cuna gr metastatic colorectal carcinoma human breast cancer european economic area rationally designed vaccine flow cytometric expertise article osada gabrilovich di human lung tumors defective antigen presentation decreased antigen presentation cancer immunotherapy conditions privacy policy
Schema {🗺️}
WebPage:
mainEntity:
headline:The effect of anti-VEGF therapy on immature myeloid cell and dendritic cells in cancer patients
description:Impairment of dendritic cells (DC), the most effective activators of anticancer immune responses, is one mechanism for defective antitumor immunity, but the causes of DC impairment are incompletely understood. We evaluated the association of impaired DC differentiation with angiogenesis-associated molecules D-dimer, vascular endothelial growth factor (VEGF), urokinase plasminogen activator (uPA), and plasminogen activator inhibitor (PAI-1) in peripheral blood from 41 patients with lung, breast, and colorectal carcinoma. Subsequently, we studied the effect of administration of the anti-VEGF antibody (bevacizumab) on DC maturation and function in vivo. Compared with healthy volunteers, cancer patients had a bias toward the immunoregulatory DC2, had deficits in DC maturation after overnight in vitro culture, and had a significant increase in immature myeloid cell progenitors of DC (0.50 ± 0.31% vs. 0.32 ± 0.16% of peripheral blood mononuclear cells, respectively, P = 0.011). A positive correlation was found between the percentage of DC2 and PAI-1 (R = 0.50) and between immature myeloid cells and VEGF (R = 0.52). Bevacizumab administration to cancer patients was associated with a decrease in the accumulation of immature progenitor cells (0.39 ± 0.30% vs. 0.27 ± 0.24%, P = 0.012) and induced a modest increase in the DC population in peripheral blood (0.47 ± 0.23% vs. 0.53 ± 0.30%). Moreover, anti-VEGF antibody treatment enhanced allo-stimulatory capacity of DC and T cell proliferation against recall antigens. These data suggest that DC differentiation is negatively associated with VEGF levels and may be one explanation for impaired anticancer immunity, especially in patients with advanced malignancies.
datePublished:2008-01-10T00:00:00Z
dateModified:2008-01-10T00:00:00Z
pageStart:1115
pageEnd:1124
sameAs:https://doi.org/10.1007/s00262-007-0441-x
keywords:
Dendritic cell
Immature myeloid cell
VEGF
Cancer
Immunity
Oncology
Immunology
Cancer Research
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-007-0441-x/MediaObjects/262_2007_441_Fig1_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-007-0441-x/MediaObjects/262_2007_441_Fig2_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-007-0441-x/MediaObjects/262_2007_441_Fig3_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-007-0441-x/MediaObjects/262_2007_441_Fig4_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-007-0441-x/MediaObjects/262_2007_441_Fig5_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-007-0441-x/MediaObjects/262_2007_441_Fig6_HTML.gif
isPartOf:
name:Cancer Immunology, Immunotherapy
issn:
1432-0851
0340-7004
volumeNumber:57
type:
Periodical
PublicationVolume
publisher:
name:Springer-Verlag
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Takuya Osada
affiliation:
name:Duke University Medical Center
address:
name:Duke University Medical Center, Durham, USA
type:PostalAddress
type:Organization
type:Person
name:Gabriel Chong
affiliation:
name:Duke University Medical Center
address:
name:Duke University Medical Center, Durham, USA
type:PostalAddress
type:Organization
type:Person
name:Robert Tansik
affiliation:
name:GlaxoSmithKline
address:
name:GlaxoSmithKline, Research Triangle Park, USA
type:PostalAddress
type:Organization
type:Person
name:Timothy Hong
affiliation:
name:Hartford Hospital
address:
name:Hartford Hospital, Hartford, USA
type:PostalAddress
type:Organization
type:Person
name:Neil Spector
affiliation:
name:Duke University Medical Center
address:
name:Duke University Medical Center, Durham, USA
type:PostalAddress
type:Organization
type:Person
name:Rakesh Kumar
affiliation:
name:GlaxoSmithKline
address:
name:GlaxoSmithKline, Research Triangle Park, USA
type:PostalAddress
type:Organization
type:Person
name:Herbert I. Hurwitz
affiliation:
name:Duke University Medical Center
address:
name:Duke University Medical Center, Durham, USA
type:PostalAddress
type:Organization
type:Person
name:Inderjit Dev
affiliation:
name:GlaxoSmithKline
address:
name:GlaxoSmithKline, Research Triangle Park, USA
type:PostalAddress
type:Organization
type:Person
name:Andrew B. Nixon
affiliation:
name:Duke University Medical Center
address:
name:Duke University Medical Center, Durham, USA
type:PostalAddress
type:Organization
type:Person
name:H. Kim Lyerly
affiliation:
name:Duke University Medical Center
address:
name:Duke University Medical Center, Durham, USA
type:PostalAddress
type:Organization
type:Person
name:Timothy Clay
affiliation:
name:Duke University Medical Center
address:
name:Duke University Medical Center, Durham, USA
type:PostalAddress
type:Organization
type:Person
name:Michael A. Morse
affiliation:
name:Duke University Medical Center
address:
name:Duke University Medical Center, Durham, USA
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:The effect of anti-VEGF therapy on immature myeloid cell and dendritic cells in cancer patients
description:Impairment of dendritic cells (DC), the most effective activators of anticancer immune responses, is one mechanism for defective antitumor immunity, but the causes of DC impairment are incompletely understood. We evaluated the association of impaired DC differentiation with angiogenesis-associated molecules D-dimer, vascular endothelial growth factor (VEGF), urokinase plasminogen activator (uPA), and plasminogen activator inhibitor (PAI-1) in peripheral blood from 41 patients with lung, breast, and colorectal carcinoma. Subsequently, we studied the effect of administration of the anti-VEGF antibody (bevacizumab) on DC maturation and function in vivo. Compared with healthy volunteers, cancer patients had a bias toward the immunoregulatory DC2, had deficits in DC maturation after overnight in vitro culture, and had a significant increase in immature myeloid cell progenitors of DC (0.50 ± 0.31% vs. 0.32 ± 0.16% of peripheral blood mononuclear cells, respectively, P = 0.011). A positive correlation was found between the percentage of DC2 and PAI-1 (R = 0.50) and between immature myeloid cells and VEGF (R = 0.52). Bevacizumab administration to cancer patients was associated with a decrease in the accumulation of immature progenitor cells (0.39 ± 0.30% vs. 0.27 ± 0.24%, P = 0.012) and induced a modest increase in the DC population in peripheral blood (0.47 ± 0.23% vs. 0.53 ± 0.30%). Moreover, anti-VEGF antibody treatment enhanced allo-stimulatory capacity of DC and T cell proliferation against recall antigens. These data suggest that DC differentiation is negatively associated with VEGF levels and may be one explanation for impaired anticancer immunity, especially in patients with advanced malignancies.
datePublished:2008-01-10T00:00:00Z
dateModified:2008-01-10T00:00:00Z
pageStart:1115
pageEnd:1124
sameAs:https://doi.org/10.1007/s00262-007-0441-x
keywords:
Dendritic cell
Immature myeloid cell
VEGF
Cancer
Immunity
Oncology
Immunology
Cancer Research
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-007-0441-x/MediaObjects/262_2007_441_Fig1_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-007-0441-x/MediaObjects/262_2007_441_Fig2_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-007-0441-x/MediaObjects/262_2007_441_Fig3_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-007-0441-x/MediaObjects/262_2007_441_Fig4_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-007-0441-x/MediaObjects/262_2007_441_Fig5_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-007-0441-x/MediaObjects/262_2007_441_Fig6_HTML.gif
isPartOf:
name:Cancer Immunology, Immunotherapy
issn:
1432-0851
0340-7004
volumeNumber:57
type:
Periodical
PublicationVolume
publisher:
name:Springer-Verlag
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Takuya Osada
affiliation:
name:Duke University Medical Center
address:
name:Duke University Medical Center, Durham, USA
type:PostalAddress
type:Organization
type:Person
name:Gabriel Chong
affiliation:
name:Duke University Medical Center
address:
name:Duke University Medical Center, Durham, USA
type:PostalAddress
type:Organization
type:Person
name:Robert Tansik
affiliation:
name:GlaxoSmithKline
address:
name:GlaxoSmithKline, Research Triangle Park, USA
type:PostalAddress
type:Organization
type:Person
name:Timothy Hong
affiliation:
name:Hartford Hospital
address:
name:Hartford Hospital, Hartford, USA
type:PostalAddress
type:Organization
type:Person
name:Neil Spector
affiliation:
name:Duke University Medical Center
address:
name:Duke University Medical Center, Durham, USA
type:PostalAddress
type:Organization
type:Person
name:Rakesh Kumar
affiliation:
name:GlaxoSmithKline
address:
name:GlaxoSmithKline, Research Triangle Park, USA
type:PostalAddress
type:Organization
type:Person
name:Herbert I. Hurwitz
affiliation:
name:Duke University Medical Center
address:
name:Duke University Medical Center, Durham, USA
type:PostalAddress
type:Organization
type:Person
name:Inderjit Dev
affiliation:
name:GlaxoSmithKline
address:
name:GlaxoSmithKline, Research Triangle Park, USA
type:PostalAddress
type:Organization
type:Person
name:Andrew B. Nixon
affiliation:
name:Duke University Medical Center
address:
name:Duke University Medical Center, Durham, USA
type:PostalAddress
type:Organization
type:Person
name:H. Kim Lyerly
affiliation:
name:Duke University Medical Center
address:
name:Duke University Medical Center, Durham, USA
type:PostalAddress
type:Organization
type:Person
name:Timothy Clay
affiliation:
name:Duke University Medical Center
address:
name:Duke University Medical Center, Durham, USA
type:PostalAddress
type:Organization
type:Person
name:Michael A. Morse
affiliation:
name:Duke University Medical Center
address:
name:Duke University Medical Center, Durham, USA
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
["Periodical","PublicationVolume"]:
name:Cancer Immunology, Immunotherapy
issn:
1432-0851
0340-7004
volumeNumber:57
Organization:
name:Springer-Verlag
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:Duke University Medical Center
address:
name:Duke University Medical Center, Durham, USA
type:PostalAddress
name:Duke University Medical Center
address:
name:Duke University Medical Center, Durham, USA
type:PostalAddress
name:GlaxoSmithKline
address:
name:GlaxoSmithKline, Research Triangle Park, USA
type:PostalAddress
name:Hartford Hospital
address:
name:Hartford Hospital, Hartford, USA
type:PostalAddress
name:Duke University Medical Center
address:
name:Duke University Medical Center, Durham, USA
type:PostalAddress
name:GlaxoSmithKline
address:
name:GlaxoSmithKline, Research Triangle Park, USA
type:PostalAddress
name:Duke University Medical Center
address:
name:Duke University Medical Center, Durham, USA
type:PostalAddress
name:GlaxoSmithKline
address:
name:GlaxoSmithKline, Research Triangle Park, USA
type:PostalAddress
name:Duke University Medical Center
address:
name:Duke University Medical Center, Durham, USA
type:PostalAddress
name:Duke University Medical Center
address:
name:Duke University Medical Center, Durham, USA
type:PostalAddress
name:Duke University Medical Center
address:
name:Duke University Medical Center, Durham, USA
type:PostalAddress
name:Duke University Medical Center
address:
name:Duke University Medical Center, Durham, USA
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Takuya Osada
affiliation:
name:Duke University Medical Center
address:
name:Duke University Medical Center, Durham, USA
type:PostalAddress
type:Organization
name:Gabriel Chong
affiliation:
name:Duke University Medical Center
address:
name:Duke University Medical Center, Durham, USA
type:PostalAddress
type:Organization
name:Robert Tansik
affiliation:
name:GlaxoSmithKline
address:
name:GlaxoSmithKline, Research Triangle Park, USA
type:PostalAddress
type:Organization
name:Timothy Hong
affiliation:
name:Hartford Hospital
address:
name:Hartford Hospital, Hartford, USA
type:PostalAddress
type:Organization
name:Neil Spector
affiliation:
name:Duke University Medical Center
address:
name:Duke University Medical Center, Durham, USA
type:PostalAddress
type:Organization
name:Rakesh Kumar
affiliation:
name:GlaxoSmithKline
address:
name:GlaxoSmithKline, Research Triangle Park, USA
type:PostalAddress
type:Organization
name:Herbert I. Hurwitz
affiliation:
name:Duke University Medical Center
address:
name:Duke University Medical Center, Durham, USA
type:PostalAddress
type:Organization
name:Inderjit Dev
affiliation:
name:GlaxoSmithKline
address:
name:GlaxoSmithKline, Research Triangle Park, USA
type:PostalAddress
type:Organization
name:Andrew B. Nixon
affiliation:
name:Duke University Medical Center
address:
name:Duke University Medical Center, Durham, USA
type:PostalAddress
type:Organization
name:H. Kim Lyerly
affiliation:
name:Duke University Medical Center
address:
name:Duke University Medical Center, Durham, USA
type:PostalAddress
type:Organization
name:Timothy Clay
affiliation:
name:Duke University Medical Center
address:
name:Duke University Medical Center, Durham, USA
type:PostalAddress
type:Organization
name:Michael A. Morse
affiliation:
name:Duke University Medical Center
address:
name:Duke University Medical Center, Durham, USA
type:PostalAddress
type:Organization
email:[email protected]
PostalAddress:
name:Duke University Medical Center, Durham, USA
name:Duke University Medical Center, Durham, USA
name:GlaxoSmithKline, Research Triangle Park, USA
name:Hartford Hospital, Hartford, USA
name:Duke University Medical Center, Durham, USA
name:GlaxoSmithKline, Research Triangle Park, USA
name:Duke University Medical Center, Durham, USA
name:GlaxoSmithKline, Research Triangle Park, USA
name:Duke University Medical Center, Durham, USA
name:Duke University Medical Center, Durham, USA
name:Duke University Medical Center, Durham, USA
name:Duke University Medical Center, Durham, USA
WebPageElement:
isAccessibleForFree:
cssSelector:.main-content
External Links {🔗}(133)
- What is the earnings of https://www.springernature.com/gp/authors?
- What's the financial intake of https://link.springernature.com/home/?
- What's https://order.springer.com/public/cart's gross income?
- Explore the financials of https://submission.nature.com/new-submission/262/3
- How much profit does https://www.springernature.com/gp/librarians/licensing/agc/journals make?
- How much profit does https://doi.org/10.1046%2Fj.1365-2567.2001.01204.x make?
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11298823 produce monthly?
- How much does http://scholar.google.com/scholar_lookup?&title=In%20vivo%20maturation%20and%20migration%20of%20dendritic%20cells&journal=Immunology&doi=10.1046%2Fj.1365-2567.2001.01204.x&volume=102&pages=255-262&publication_year=2001&author=Flores-Romo%2CL gross monthly?
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9679955 generate?
- What's the income of http://scholar.google.com/scholar_lookup?&title=Optimization%20of%20the%20sequence%20of%20antigen%20loading%20and%20CD40%20ligand-induced%20maturation%20of%20dendritic%20cells&journal=Cancer%20Res&volume=58&pages=2965-2968&publication_year=1998&author=Morse%2CMA&author=Lyerly%2CHK&author=Gilboa%2CE&author=Nair%2CSK?
- What's the profit of https://doi.org/10.1038%2Fsj.bjc.6601114?
- How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12888826 generate?
- Explore the financials of http://scholar.google.com/scholar_lookup?&title=CD1a-positive%20infiltrating-dendritic%20cell%20density%20and%205-year%20survival%20from%20human%20breast%20cancer&journal=Br%20J%20Cancer&doi=10.1038%2Fsj.bjc.6601114&volume=89&pages=533-538&publication_year=2003&author=Coventry%2CBJ&author=Morton%2CJ
- Learn how profitable https://doi.org/10.3109%2F00313029309090853 is on a monthly basis
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8164994's financial summary
- What's the income generated by http://scholar.google.com/scholar_lookup?&title=S100%20positive%20dendritic%20cells%20in%20human%20lung%20tumors%20associated%20with%20cell%20differentiation%20and%20enhanced%20survival&journal=Pathology&doi=10.3109%2F00313029309090853&volume=25&pages=338-343&publication_year=1993&author=Zeid%2CNA&author=Muller%2CHK each month?
- What are the total earnings of https://doi.org/10.1084%2Fjem.193.2.233?
- How much cash flow does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11208863 have monthly?
- How profitable is http://scholar.google.com/scholar_lookup?&title=Antigen-specific%20inhibition%20of%20effector%20T%20cell%20function%20in%20humans%20after%20injection%20of%20immature%20dendritic%20cells&journal=J%20Exp%20Med&doi=10.1084%2Fjem.193.2.233&volume=193&pages=233-238&publication_year=2001&author=Dhodapkar%2CMV&author=Steinman%2CRM&author=Krasovsky%2CJ&author=Munz%2CC&author=Bhardwaj%2CN?
- How much does https://doi.org/10.1006%2Fcimm.1996.0139 gross monthly?
- What's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8665590?
- Profit of http://scholar.google.com/scholar_lookup?&title=Dendritic%20cells%20in%20antitumor%20immune%20responses.%20I.%20Defective%20antigen%20presentation%20in%20tumor-bearing%20hosts&journal=Cell%20Immunol&doi=10.1006%2Fcimm.1996.0139&volume=170&pages=101-110&publication_year=1996&author=Gabrilovich%2CDI&author=Ciernik%2CIF&author=Carbone%2CDP
- How much income is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9815709 earning monthly?
- Financial intake of http://scholar.google.com/scholar_lookup?&title=Decreased%20antigen%20presentation%20by%20dendritic%20cells%20in%20patients%20with%20breast%20cancer&journal=Clin%20Cancer%20Res&volume=3&pages=483-490&publication_year=1997&author=Gabrilovich%2CDI&author=Corak%2CJ&author=Ciernik%2CIF&author=Kavanaugh%2CD&author=Carbone%2CDP
- Explore the financials of https://doi.org/10.1182%2Fblood.V100.1.230
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12070032's financial summary
- What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=Dendritic%20cells%20are%20functionally%20defective%20in%20multiple%20myeloma%3A%20the%20role%20of%20interleukin-6&journal=Blood&doi=10.1182%2Fblood.V100.1.230&volume=100&pages=230-237&publication_year=2002&author=Ratta%2CM&author=Fagnoni%2CF&author=Curti%2CA&author=Vescovini%2CR&author=Sansoni%2CP&author=Oliviero%2CB&author=Fogli%2CM&author=Ferri%2CE&author=Della%20Cuna%2CGR&author=Tura%2CS&author=Baccarani%2CM&author=Lemoli%2CRM?
- Monthly income for https://doi.org/10.1016%2FS0198-8859%2899%2900114-7
- What is the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10626734?
- What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=Cultures%20derived%20from%20peripheral%20blood%20CD34%2B%20progenitor%20cells%20of%20head%20and%20neck%20cancer%20patients%20and%20from%20cord%20blood%20are%20functionally%20different&journal=Hum%20Immunol&doi=10.1016%2FS0198-8859%2899%2900114-7&volume=60&pages=1207-1215&publication_year=1999&author=Lathers%2CDM&author=Lubbers%2CE&author=Beal%2CNM&author=Wright%2CMA&author=Young%2CMR?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11123353 gross monthly?
- How much does http://scholar.google.com/scholar_lookup?&title=Increased%20production%20of%20immature%20myeloid%20cells%20in%20cancer%20patients%3A%20a%20mechanism%20of%20immunosuppression%20in%20cancer&journal=J%20Immunol&volume=166&pages=678-689&publication_year=2001&author=Almand%2CB&author=Clark%2CJI&author=Nikitina%2CE&author=Beynen%2CJ&author=English%2CNR&author=Knight%2CSC&author=Carbone%2CDP&author=Gabrilovich%2CDI gross monthly?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12111117 income
- http://scholar.google.com/scholar_lookup?&title=Immature%20myeloid%20cells%20and%20cancer-associated%20immune%20suppression&journal=Cancer%20Immunol%20Immunother&doi=10.1007%2Fs00262-002-0280-8&volume=51&pages=293-298&publication_year=2002&author=Kusmartsev%2CS&author=Gabrilovich%2CDI income
- How much does https://doi.org/10.1158%2F0008-5472.CAN-03-1715 generate monthly?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=14871848 pull in monthly?
- How much does http://scholar.google.com/scholar_lookup?&title=Role%20of%20immature%20myeloid%20Gr-1%2B%20cells%20in%20the%20development%20of%20antitumor%20immunity&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-03-1715&volume=64&pages=1130-1139&publication_year=2004&author=Li%2CQ&author=Pan%2CPY&author=Gu%2CP&author=Xu%2CD&author=Chen%2CSH earn?
- How profitable is https://doi.org/10.1016%2Fj.semcancer.2005.07.005?
- Find out how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16168663 earns monthly
- How much profit is http://scholar.google.com/scholar_lookup?&title=Myeloid%20suppressor%20cells%20in%20cancer%3A%20recruitment%2C%20phenotype%2C%20properties%2C%20and%20mechanisms%20of%20immune%20suppression&journal=Semin%20Cancer%20Biol&doi=10.1016%2Fj.semcancer.2005.07.005&volume=16&pages=53-65&publication_year=2006&author=Serafini%2CP&author=Borrello%2CI&author=Bronte%2CV making per month?
- Check the income stats for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10667560
- Get to know http://scholar.google.com/scholar_lookup?&title=Regulation%20of%20angiogenesis%20via%20vascular%20endothelial%20growth%20factor%20receptors&journal=Cancer%20Res&volume=60&pages=203-212&publication_year=2000&author=Veikkola%2CT&author=Karkkainen%2CM&author=Claesson-Welsh%2CL&author=Alitalo%2CK's earnings
- How much profit does https://doi.org/10.1016%2F0958-1669%2895%2980111-1 generate?
- How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8527839 make?
- Get to know http://scholar.google.com/scholar_lookup?&title=VEGF-mediated%20tumour%20angiogenesis%3A%20a%20new%20target%20for%20cancer%20therapy&journal=Curr%20Opin%20Biotechnol&doi=10.1016%2F0958-1669%2895%2980111-1&volume=6&pages=675-680&publication_year=1995&author=Martiny-Baron%2CG&author=Marme%2CD's earnings
- How much does https://doi.org/10.1038%2Fnm1096-1096 rake in every month?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8837607 net monthly?
- What is the earnings of http://scholar.google.com/scholar_lookup?&title=Production%20of%20vascular%20endothelial%20growth%20factor%20by%20human%20tumors%20inhibits%20the%20functional%20maturation%20of%20dendritic%20cells&journal=Nat%20Med&doi=10.1038%2Fnm1096-1096&volume=2&pages=1096-1103&publication_year=1996&author=Gabrilovich%2CDI&author=Chen%2CHL&author=Girgis%2CKR&author=Cunningham%2CHT&author=Meny%2CGM&author=Nadaf%2CS&author=Kavanaugh%2CD&author=Carbone%2CDP?
- Discover the revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15611243
- What are the total earnings of http://scholar.google.com/scholar_lookup?&title=Differential%20roles%20of%20vascular%20endothelial%20growth%20factor%20receptors%201%20and%202%20in%20dendritic%20cell%20differentiation&journal=J%20Immunol&volume=174&pages=215-222&publication_year=2005&author=Dikov%2CMM&author=Ohm%2CJE&author=Ray%2CN&author=Tchekneva%2CEE&author=Burlison%2CJ&author=Moghanaki%2CD&author=Nadaf%2CS&author=Carbone%2CDP?
- What's the financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9570538?
- What's the income of http://scholar.google.com/scholar_lookup?&title=Vascular%20endothelial%20growth%20factor%20affects%20dendritic%20cell%20maturation%20through%20the%20inhibition%20of%20nuclear%20factor-kappa%20B%20activation%20in%20hematopoietic%20progenitor%20cells&journal=J%20Immunol&volume=160&pages=1224-1232&publication_year=1998&author=Oyama%2CT&author=Ran%2CS&author=Ishida%2CT&author=Nadaf%2CS&author=Kerr%2CL&author=Carbone%2CDP&author=Gabrilovich%2CDI?
- Explore the financials of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10537366
- How much does http://scholar.google.com/scholar_lookup?&title=Antibodies%20to%20vascular%20endothelial%20growth%20factor%20enhance%20the%20efficacy%20of%20cancer%20immunotherapy%20by%20improving%20endogenous%20dendritic%20cell%20function&journal=Clin%20Cancer%20Res&volume=5&pages=2963-2970&publication_year=1999&author=Gabrilovich%2CDI&author=Ishida%2CT&author=Nadaf%2CS&author=Ohm%2CJE&author=Carbone%2CDP net monthly?
- Learn how profitable http://scholar.google.com/scholar_lookup?&title=Isolation%20and%20characterization%20of%20human%20peripheral%20blood%20dendritic%20cells&journal=J%20Immunol&volume=150&pages=821-834&publication_year=1994&author=Thomas%2CR&author=Davis%2CLS&author=Lipsky%2CPE is on a monthly basis
- https://doi.org/10.1038%2Fnrc1971's total income per month
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17036040's revenue stream
- How much does http://scholar.google.com/scholar_lookup?&title=The%20multifaceted%20circulating%20endothelial%20cell%20in%20cancer%3A%20towards%20marker%20and%20target%20identification&journal=Nat%20Rev%20Cancer&doi=10.1038%2Fnrc1971&volume=6&pages=835-845&publication_year=2006&author=Bertolini%2CF&author=Shaked%2CY&author=Mancuso%2CP&author=Kerbel%2CRS net monthly?
- What's the income generated by http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10648408 each month?
- Earnings of http://scholar.google.com/scholar_lookup?&title=Expression%20of%20VEGFR-2%20and%20AC133%20by%20circulating%20human%20CD34%28%2B%29%20cells%20identifies%20a%20population%20of%20functional%20endothelial%20precursors&journal=Blood&volume=95&pages=952-958&publication_year=2000&author=Peichev%2CM&author=Naiyer%2CAJ&author=Pereira%2CD&author=Zhu%2CZ&author=Lane%2CWJ&author=Williams%2CM&author=Oz%2CMC&author=Hicklin%2CDJ&author=Witte%2CL&author=Moore%2CMA&author=Rafii%2CS
- What's the revenue for https://doi.org/10.1038%2Fsj.bjc.6600069?
- Monthly income for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11875705
- Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=Plasma%20fibrin%20D-dimer%20levels%20correlate%20with%20tumour%20volume%2C%20progression%20rate%20and%20survival%20in%20patients%20with%20metastatic%20breast%20cancer&journal=Br%20J%20Cancer&doi=10.1038%2Fsj.bjc.6600069&volume=86&pages=389-395&publication_year=2002&author=Dirix%2CLY&author=Salgado%2CR&author=Weytjens%2CR&author=Colpaert%2CC&author=Benoy%2CI&author=Huget%2CP&author=Dam%2CP&author=Prove%2CA&author=Lemmens%2CJ&author=Vermeulen%2CP
- How much does https://doi.org/10.1083%2Fjcb.152.4.777 make?
- Learn how profitable http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11266468 is on a monthly basis
- What's the revenue for http://scholar.google.com/scholar_lookup?&title=The%20plasminogen%20activator%20inhibitor%20PAI-1%20controls%20in%20vivo%20tumor%20vascularization%20by%20interaction%20with%20proteases%2C%20not%20vitronectin.%20Implications%20for%20antiangiogenic%20strategies&journal=J%20Cell%20Biol&doi=10.1083%2Fjcb.152.4.777&volume=152&pages=777-784&publication_year=2001&author=Bajou%2CK&author=Masson%2CV&author=Gerard%2CRD&author=Schmitt%2CPM&author=Albert%2CV&author=Praus%2CM&author=Lund%2CLR&author=Frandsen%2CTL&author=Brunner%2CN&author=Dano%2CK&author=Fusenig%2CNE&author=Weidle%2CU&author=Carmeliet%2CG&author=Loskutoff%2CD&author=Collen%2CD&author=Carmeliet%2CP&author=Foidart%2CJM&author=Noel%2CA?
- How much does https://doi.org/10.1136%2Fmp.53.6.307 net monthly?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11193049 pull in monthly?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Plasminogen%20activator%20system%2C%20vascular%20endothelial%20growth%20factor%2C%20and%20colorectal%20cancer%20progression&journal=Mol%20Pathol&doi=10.1136%2Fmp.53.6.307&volume=53&pages=307-312&publication_year=2000&author=Baker%2CEA&author=Bergin%2CFG&author=Leaper%2CDJ generate?
- How much cash flow does https://doi.org/10.1002%2Fcncr.20336 have monthly?
- Get to know http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15221991's earnings
- What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=Circulating%20D-dimer%20levels%20are%20better%20predictors%20of%20overall%20survival%20and%20disease%20progression%20in%20patients%20with%20metastatic%20colorectal%20carcinoma&journal=Cancer&doi=10.1002%2Fcncr.20336&volume=101&pages=77-82&publication_year=2004&author=Blackwell%2CK&author=Hurwitz%2CH&author=Lieberman%2CG&author=Novotny%2CW&author=Snyder%2CS&author=Dewhirst%2CM&author=Greenberg%2CC?
- Earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12223523
- How much income does http://scholar.google.com/scholar_lookup?&title=Multiple%20signals%20are%20required%20for%20maturation%20of%20human%20dendritic%20cells%20mobilized%20in%20vivo%20with%20Flt3%20ligand&journal=J%20Leukoc%20Biol&volume=72&pages=546-553&publication_year=2002&author=Mosca%2CPJ&author=Hobeika%2CAC&author=Colling%2CK&author=Clay%2CTM&author=Thomas%2CEK&author=Caron%2CD&author=Lyerly%2CHK&author=Morse%2CMA have?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9834220 generate monthly?
- How much does http://scholar.google.com/scholar_lookup?&title=Vascular%20endothelial%20growth%20factor%20inhibits%20the%20development%20of%20dendritic%20cells%20and%20dramatically%20affects%20the%20differentiation%20of%20multiple%20hematopoietic%20lineages%20in%20vivo&journal=Blood&volume=92&pages=4150-4166&publication_year=1998&author=Gabrilovich%2CD&author=Ishida%2CT&author=Oyama%2CT&author=Ran%2CS&author=Kravtsov%2CV&author=Nadaf%2CS&author=Carbone%2CDP pull in?
- What is the monthly revenue of https://doi.org/10.1385%2FIR%3A23%3A2-3%3A263?
- What's the revenue for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11444391?
- What's the profit of http://scholar.google.com/scholar_lookup?&title=VEGF%20as%20a%20mediator%20of%20tumor-associated%20immunodeficiency&journal=Immunol%20Res&doi=10.1385%2FIR%3A23%3A2-3%3A263&volume=23&pages=263-272&publication_year=2001&author=Ohm%2CJE&author=Carbone%2CDP?
- What's the financial outcome of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11792750?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Pooled%20analysis%20of%20prognostic%20impact%20of%20urokinase-type%20plasminogen%20activators%20and%20its%20inhibitor%20PAI-1%20in%208377%20breast%20cancer%20patients&journal=J%20Natl%20Cancer%20Inst&volume=94&pages=116-128&publication_year=2002&author=Look%2CMP&author=Putten%2CWL&author=Duffy%2CMJ&author=Harbeck%2CN&author=Christensen%2CIJ&author=Thomssen%2CC&author=Kates%2CR&author=Spyratos%2CF&author=Ferno%2CM&author=Eppenberger-Castori%2CS&author=Sweep%2CCG&author=Ulm%2CK&author=Peyrat%2CJP&author=Martin%2CPM&author=Magdelenat%2CH&author=Brunner%2CN&author=Duggan%2CC&author=Lisboa%2CBW&author=Bendahl%2CPO&author=Quillien%2CV&author=Daver%2CA&author=Ricolleau%2CG&author=Meijer-van%20Gelder%2CME&author=Manders%2CP&author=Fiets%2CWE&author=Blankenstein%2CMA&author=Broet%2CP&author=Romain%2CS&author=Daxenbichler%2CG&author=Windbichler%2CG&author=Cufer%2CT&author=Borstnar%2CS&author=Kueng%2CW&author=Beex%2CLV&author=Klijn%2CJG&author=O%E2%80%99Higgins%2CN&author=Eppenberger%2CU&author=Janicke%2CF&author=Schmitt%2CM&author=Foekens%2CJA generate?
- Check the income stats for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8518031
- http://scholar.google.com/scholar_lookup?&title=Plasminogen%20activators%20and%20plasminogen%20activator%20inhibitors%20in%20human%20colorectal%20carcinoma%20tissues%20are%20not%20expressed%20by%20the%20tumour%20cells&journal=Eur%20J%20Cancer&volume=29A&pages=1184-1189&publication_year=1993&author=Koretz%2CK&author=Moller%2CP&author=Schwartz-Albiez%2CR's total income per month
- Get to know what's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10815894
- Financial intake of http://scholar.google.com/scholar_lookup?&title=Clinical%20significance%20of%20defective%20dendritic%20cell%20differentiation%20in%20cancer&journal=Clin%20Cancer%20Res&volume=6&pages=1755-1766&publication_year=2000&author=Almand%2CB&author=Resser%2CJR&author=Lindman%2CB&author=Nadaf%2CS&author=Clark%2CJI&author=Kwon%2CED&author=Carbone%2CDP&author=Gabrilovich%2CDI
- How much money does https://doi.org/10.1016%2Fj.bbrc.2005.06.065 generate?
- Learn how profitable http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16002046 is on a monthly basis
- Revenue of http://scholar.google.com/scholar_lookup?&title=Vascular%20endothelial%20growth%20factor%20impairs%20the%20functional%20ability%20of%20dendritic%20cells%20through%20Id%20pathways&journal=Biochem%20Biophys%20Res%20Commun&doi=10.1016%2Fj.bbrc.2005.06.065&volume=334&pages=193-198&publication_year=2005&author=Laxmanan%2CS&author=Robertson%2CSW&author=Wang%2CE&author=Lau%2CJS&author=Briscoe%2CDM&author=Mukhopadhyay%2CD
- Learn about the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17086423
- How much profit is http://scholar.google.com/scholar_lookup?&title=Vascular%20endothelial%20growth%20factor%20inhibits%20the%20function%20of%20human%20mature%20dendritic%20cells%20mediated%20by%20VEGF%20receptor-2&journal=Cancer%20Immunol%20Immunother&doi=10.1007%2Fs00262-006-0234-7&volume=56&pages=761-770&publication_year=2007&author=Mimura%2CK&author=Kono%2CK&author=Takahashi%2CA&author=Kawaguchi%2CY&author=Fujii%2CH making per month?
- Financial intake of https://citation-needed.springer.com/v2/references/10.1007/s00262-007-0441-x?format=refman&flavour=references
- What are the total earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Takuya%20Osada?
- Profit of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Takuya%20Osada%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- What's the financial outcome of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Gabriel%20Chong?
- Get to know https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Gabriel%20Chong%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's earnings
- How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Robert%20Tansik produce monthly?
- How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Robert%20Tansik%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en bring in?
- How much income is https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Timothy%20Hong earning monthly?
- What's the financial intake of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Timothy%20Hong%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much income is https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Neil%20Spector earning monthly?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Neil%20Spector%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en bring in each month?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Rakesh%20Kumar make?
- Explore the financials of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Rakesh%20Kumar%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How much money does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Herbert%20I.%20Hurwitz make?
- Get to know https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Herbert%20I.%20Hurwitz%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's earnings
- Income figures for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Inderjit%20Dev
- How much money does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Inderjit%20Dev%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
- What is the earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Andrew%20B.%20Nixon?
- https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Andrew%20B.%20Nixon%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's total income per month
- Revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=H.%20Kim%20Lyerly
- What are the total earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22H.%20Kim%20Lyerly%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- Learn how profitable https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Timothy%20Clay is on a monthly basis
- Get to know https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Timothy%20Clay%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's earnings
- Profit of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Michael%20A.%20Morse
- What's https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Michael%20A.%20Morse%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's gross income?
- How much does https://s100.copyright.com/AppDispatchServlet?title=The%20effect%20of%20anti-VEGF%20therapy%20on%20immature%20myeloid%20cell%20and%20dendritic%20cells%20in%20cancer%20patients&author=Takuya%20Osada%20et%20al&contentID=10.1007%2Fs00262-007-0441-x©right=Springer-Verlag&publication=0340-7004&publicationDate=2008-01-10&publisherName=SpringerNature&orderBeanReset=true bring in each month?
- What's https://citation-needed.springer.com/v2/references/10.1007/s00262-007-0441-x?format=refman&flavour=citation's gross income?
- Explore the financials of https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral
- How much profit is https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research making per month?
- https://www.springernature.com/gp/products's total income per month
- What is the earnings of https://www.springernature.com/gp/librarians?
- How much cash flow does https://www.springernature.com/gp/societies have monthly?
- Profit of https://www.springernature.com/gp/partners
- https://www.springer.com/'s revenue stream
- Get to know what's the income of https://www.nature.com/
- How much does https://www.biomedcentral.com/ pull in?
- Discover the revenue of https://www.palgrave.com/
- What's the monthly income of https://www.apress.com/?
- What's the monthly income of https://www.springernature.com/gp/legal/ccpa?
- How much does https://www.springernature.com/gp/info/accessibility make?
- What's the monthly income of https://support.springernature.com/en/support/home?
- How much revenue does https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations generate?
- How much does https://www.springernature.com/ pull in monthly?
Analytics and Tracking {📊}
- Google Tag Manager
Libraries {📚}
- Clipboard.js
- Prism.js
CDN Services {📦}
- Crossref